Windlas Biotech DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.77×	0.76×	0.76×	0.75×	0.75×
	1.16×	1.18×	1.20×	1.19×	1.19×
	7.9%	8.2%	8.7%	10.2%	9.3%
	1.08×	1.08×	1.10×	1.09×	1.01×
	1.56×	1.56×	1.50×	1.39×	1.31×
	11.9%	12.4%	13.2%	14.0%	11.0%
	12.2%	12.2%	12.7%	13.6%	10.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

WINDLAS₹923.40

Windlas Biotech Limited

· Pharma & Health

₹ CrorePeersHESTERBIO INDOCO SAIPARENT SYNCOMF PANACEABIO NGLFINE HIKAL JAGSNPHARMMcap ₹1,949 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.75	0.75	0.76	0.76	0.77
Interest Burden (Pretax/EBIT) ×	1.19	1.19	1.20	1.18	1.16
EBIT Margin %	9.33	10.25	8.70	8.18	7.89
Asset Turnover ×	1.01	1.09	1.10	1.08	1.08
Financial Leverage (Assets/Equity) ×	1.31	1.39	1.50	1.56	1.56
ROE (5-step product, year-end total equity) %	11.03	13.97	13.20	12.40	11.90
ROE (owners' profit / average owners' equity) %	10.69	13.63	12.69	12.23	12.23

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.